Ms. Mercedes A. Walton

• 
  www.planetbump.com/resource_center/subpage_noad.asp?ID= - [Cached Version]
  Published on: 6/14/2007    Last Visited: 1/5/2008  

  "As Cryo-Cell continues to execute the Company's long-term strategy, the current Board and management team are guided along this journey by a collective vision of success based on the team's expansive business and technological knowledge, experience and industry-recognized expertise", stated Mercedes Walton, Cryo-Cell's Chairman & CEO.

• 
  dallas.bizjournals.com/tampabay/stories/2007/07/30/dail - [Cached Version]
  Published on: 8/1/2007    Last Visited: 12/7/2007  

  Walton, Peterschmidt named to Savvis board [St.Louis]
  ...
  The board's slate was made up of all the five current directors, including Mercedes Walton, chairman and chief executive, and a sixth nominee, Andrew "Flip" Filipowski, a one-time critic of the company and a major shareholder.

• 
  www.cryo-cell.com/resource_center/subpage_noad.asp?ID=1 - [Cached Version]
  Published on: 11/28/2005    Last Visited: 3/14/2007  

  "Cryo-Cell is extremely proud to have achieved another major milestone with the attainment of our ISO 9001:2000 certification," stated Mercedes Walton, Chairman & CEO.

• 
  www.cryo-cell.com/resource_center/subpage_noad.asp?ID=1 - [Cached Version]
  Published on: 12/6/2005    Last Visited: 3/14/2007  

  Mercedes Walton, Chairman and CEO commented, "We are pleased and proud to introduce the new features of Cryo-Cell's enhanced U-Cord Service.Our goal is to provide Cryo-Cell clients with a premium and effortless, end-to-end service that helps families establish a unique healthcare asset that we believe will increase in value over time as anticipated new therapeutic applications emerge.The Cryo-Cell Cares Program, in particular, is another industry innovation reflective of Cryo-Cell's leadership as both a high-tech and high-touch service provider."
  
  Cryo-Cell is the first in the industry to offer the Cryo-Cell Client for Life Program that enables clients to lock-in today's U-Cord Service prices for the family's future newborns and the $10,000 Cryo-Cell Cares Payment that provides families with a lump-sum payment to assist with personal living expenses in the event that their child's Cryo-Cell-processed and stored cord blood specimen is utilized for bone marrow transplant.
  
  Ms. Walton continued, "We believe that Cryo-Cell's enhanced U-Cord offer provides clients with the highest accredited quality, most innovative and superior-value private cord blood service available in today's market.

• 
  stage.celle.com/mediaKit_WaltonBio.aspx - [Cached Version]
  Published on: 8/16/2008    Last Visited: 8/16/2008  

  Mercedes Walton, Chairman & CEO
  ...
  Mercedes WaltonMs. Walton has served as Director of Cryo-Cell since October 2000, and as Chairman of the Board since June 2002.Prior to joining Cryo-Cell, Ms. Walton served as CEO of Ralston Hill Consulting LLC, a privately held business development and strategic management consulting practice.Ms. Walton previously served as President and Chief Operating Officer of Applied Digital Solutions, Inc. (NASDAQ: ADSX) in Palm Beach, Florida.She was responsible for corporate restructuring and guiding the company's strategic planning and launch of Digital Angel (AMEX:DOC), an advanced wireless corporation.Prior to joining Applied Digital Solutions, she was corporate Vice President of Strategy and Business Development at AT&T (NYSE:T).During her 24-year tenure with AT&T, Ms. Walton held positions in business and consumer operations, global network operations, engineering, marketing & sales and product management.Ms. Walton holds a BA degree from Smith College and Master's degrees from Harvard University and Massachusetts Institute of Technology (MIT).Prior to its acquisition by Black Box Corporation (NASDAQ:BBOX), Ms. Walton served on the Board of Directors of Norstan, Inc (NASDAQ:NRRD), where she served on the Audit Committee and chaired the Corporate Governance Committee.Ms. Walton currently serves on the Board of Directors for SAVVIS, Inc. (NASDAQ: SVVS) where she is a member of the Corporate Governance Committee.

• 
  www.sec.gov/Archives/edgar/data/1209204/0001181431-08-0 - [Cached Version]
  Published on: 8/26/2008    Last Visited: 8/27/2008  

  0001209204 WALTON MERCEDES 700 BROOKER CREEK BLVD. SUITE 1800 OLDSMAR FL 34677 1 1 0 0 CEO

• 
  www.prnewswire.com/cgi-bin/stories.pl?ACCT=104&STORY=/w - [Cached Version]
  Published on: 9/24/2008    Last Visited: 9/24/2008  

  "We believe that the globalization of C'elle may generate significant worldwide awareness and interest in the potential of future stem cell therapeutic breakthroughs," said Mercedes Walton, Chairman and CEO of Cryo-Cell International."We are pleased that our exclusive service, C'elle, will be introduced to women in different countries around the world.This exclusive and innovative service, based on Cryo-Cell's expansive intellectual property portfolio, provides women with the opportunity to store their own stem cells for future potential therapeutic benefit.""Clinical trials are now underway to test the safety and efficacy of stem cells found in menstrual blood (MenSCs) in animal models for diabetes, neurodegenerative and cardiovascular regenerative therapies," Walton continued.

• 
  stage.celle.com/mediaKit_ManagementBios.aspx - [Cached Version]
  Published on: 8/16/2008    Last Visited: 8/16/2008  

  Mercedes Walton, Chairman & CEO

• 
  www.crmz.com/Report/ReportPreview.asp?BusinessId=6369 - [Cached Version]
  Published on: 6/15/2008    Last Visited: 6/15/2008  

  Mercedes A. Walton
  Chairman of the Board, Chief Executive Officer
  CRYO-CELL International, Inc.

• 
  www.planetbump.com/investor%5Frelations/subpage_noad.as - [Cached Version]
  Published on: 9/24/2008    Last Visited: 10/8/2008  

  "We believe that the globalization of C`elle may generate significant worldwide awareness and interest in the potential of future stem cell therapeutic breakthroughs," said Mercedes Walton, Chairman and CEO of Cryo-Cell International."We are pleased that our exclusive service, C'elle, will be introduced to women in different countries around the world.This exclusive and innovative service, based on Cryo-Cell's expansive intellectual property portfolio, provides women with the opportunity to store their own stem cells for future potential therapeutic benefit."
  
  "Clinical trials are now underway to test the safety and efficacy of stem cells found in menstrual blood (MenSCs) in animal models for diabetes, neurodegenerative and cardiovascular regenerative therapies," Walton continued.

Page:  1 2 3 4 5